Cathepsin B and human tumor progression

Biological Chemistry

Volumn 379, Issue 2, 1998, Pages 113-123

  Yan, Shiqing ^a   Sameni, Mansoureh ^a   Sloane, Bonnie F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin B; Intracellular trafficking; Lysosomal enzymes; Malignant progression; Secretion; Tumors

Indexed keywords

CATHEPSIN B; MESSENGER RNA;

CANCER GENETICS; CANCER INVASION; HUMAN; PRIORITY JOURNAL; REVIEW; STAINING; TUMOR GROWTH;

ANIMALS; CATHEPSIN B; DISEASE PROGRESSION; HUMANS; NEOPLASMS;

EID: 0031884265     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Achkar, C., Gong, Q.M., Frankfater, A., and Bajkowski, A.S. (1990). Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts. J. Biol. Chem. 265, 13650-13654.
2. Adenis, A., Huet, G., Zerimech, F., Hecquet, B., Balduyck, M., and Peyrat, J.P. (1995). Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinic-pathological parameters. Cancer Lett. 96, 267-275.
3. Aimes, R.T., and Quigley, J.P. (1995). Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem. 270, 5872-5876.
4. Ausprunk, D.H., and Folkman, J. (1977). Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during angiogenesis. Microvasc. Res. 14, 53-65.
5. Authier, F., Mort, J.S., Bell, A.W., Posner, B.I., and Bergeron, J.J. (1995). Proteolysis of glucagon within hepatic endosomes by membrane-associated cathepsins B and D. J. Biol. Chem. 270, 15798-15807.
6. Benitez-Bribiesca, L., Martinez, G., Ruiz, M.T., Gutierrez-Delgado, F., and Utrera, D. (1995). Proteinase activity in invasive cancer of the breast. Correlation with tumor progression. Arch. Med. Res. 26, Spec S163-S168.
7. Berquin, I.M., and Sloane, B.F. (1995). Cysteine proteinase and tumor progression. Perspective in Drug Discovery and Design. 2, 371-388.
8. Berquin, I.M., and Sloane, B.F. (1996). Cathepsin B expression in human tumors. In: Intracellular Protein Metabolism, K. Suzuki and J. Bond, eds.(New York, USA: Plenum Press), pp. 281-294.
9. Berquin, I.M., Cao. L., Fong, D., and Sloane, B.F. (1995). Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-enco-ding gene. Gene. 159, 143-149.
10. Braulke, T., Tippmer, S., Matzner, U., Gartung, C., and von Figura, K. (1992). Mannose-6-phosphate/insulin-like growth factor II receptor in I-cell disease fibroblasts: increased synthesis and defective regulation of cell surface expression. Biochim. Biophys. Acta. 1138, 334-342.
11. Brown, W.J., Goodhouse, J., and Farquhar, M.G. (1986). Mannose-6-phosphate receptors for lysosomal enzymes cycle between the Golgi complex and endosomes. J. Cell Biol. 103, 1235-1247.
12. Buck, M.R., Karustis, D.G., Day, N.A., Honn, K.V., and Sloane, B.F. (1992). Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumor tissues. Biochem. J. 282, 273-278.
13. Campo, E., Munoz, J., Miquel, R., Palacin, A., Cardesa, A., Sloane, B.F., and Emmert-Buck, M.R. (1994). Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am. J. Pathol. 145, 301-309.
14. Cao, L., Taggart, R.T., Berquin, I.M., Moin, K., Fong, D., and Sloane, B.F. (1994). Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene. Gene. 139, 163-169.
15. Capony, F., Braulke, T., Rougeot, C., Roux, S., Montcourrier, P., and Rochefort, H. (1994). Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. Exp. Cell. Res. 215, 154-163.
16. Castiglioni, T., Merino, M. J., Elsner, B., Lah, T.T., Sloane, B.F., Emmert-Buck, M.R. (1994). Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum. Pathol. 25, 857-862
17. Chan, S.J., San Segundo, B., McCormick, M.B., and Sloane, D.F. (1986) Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proc. Natl. Acad. Sci. USA 83, 7721-7725.
18. Corticchiato, O., Cajot, J.F., Abrahamson, M., Chan, S.J., Keppler, D., and Sordat, B. (1992). Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation. Int. J. Cancer 52, 645-652.
19. Dalet-Fumeron, V., Guinec, N., and Pagano, M. (1993). In vitro activation of pro-cathepsin B by three serine proteinases: leukocyte elastase, cathepsin G, and the urokinase-type plasminogen activator. FEBS Lett. 332, 251-254.
20. Dalet-Fumeron, V., Boudjennah, L., and Pagano, M. (1996). Competition between plasminogen and procathepsin B as a probe to demonstrate the in vitro activation of procathepsin B by the tissue plasminogen activator. Arch. Biochem. Biophys. 335, 351-357.
21. Dehrmann, F.M., Elliott, E., and Dennison, C. (1996). Reductive activation markedly increases the stability of cathepsins B and L to extracellular ionic conditions. Biol. Chem. Hoppe Seyler. 377, 391-394.
22. De Stefanis, D., Demoz, M., Dragonetti, A., Houri, J.J., Ogier-Denis, E., Codogno, P., Baccino, F.M., and Isidoro, C. (1997). Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res. 289, 109-117.
23. Ebert, W., Knoch, H., Werle, B., Trefz, G., Muley, T., and Spiess, E. (1994). Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res. 14, 895-899.
24. Emmert-Buck, M.R., Roth, M.J., Zhuang, Z., Campo, E., Rozhin, J., Sloane, B.F., Liotta, L.A., and Stetler-Stevenson, W.G. (1994). Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol. 145, 1285-1290.
25. Fong, D., Calhoun, D.H., Hsieh, W.T., Lee, B., and Wells, R.D. (1986) Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B. Proc. Natl. Acad. Sci. USA 83, 2909-2913.
26. Fong, D., Chan, M.M., Hsieh, W.T., Menninger, J.C., and Ward, D.C. (1992). Confirmation of the human cathepsin B gene (CTSB) assignment to chromosome 8. Hum. Genet. 89, 10-12.
27. Freimert, C., Closs, E.I., Silbermann, M., Erfle, V., and Strauss, P.G. (1991). Isolation of a cathepsin B-encoding cDNA from murineosteogenic cells. Gene. 103, 259-261.
28. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W.G., and Quaranta, V. (1997). Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228.
29. Gong, Q., Chan, S.J., Bajkowski, A.S., Steiner, D.F., and Frankfater, A. (1993). Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol. 12, 299-309.
30. Hanewinkel, H., Glossl, J., and Kresse, H. (1987). Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J. Biol. Chem. 262, 12351-12355.
31. Havenith, M.G., Arends, J.W., Simon, R., Volovics, A., Wiggers, T., and Bosman, F.T. (1988). Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer 62, 2207-2211.
32. Heidtmann, H.H., Salge, U., Abrahamson, M., Bencina, M., Kastelic, L., Kopitar-Jerala, N., Turk, V., and Lah, TT. (1997). Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Clin. Exp. Metastasis 15, 368-381.
33. Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., and Tateishi, R. (1993). Cathepsin B expression in tumor cells and laminin distribution in pulmonary adenocarcinoma. J. Clin. Pathol. 46, 18-22.
34. Hirano, T., Manabe, T., and Takeuchi, S. (1993). Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis. Cancer Lett. 70, 41-44.
35. Honn, K.V., Timar, J., Rozhin, J., Bazaz, R., Sameni, M., Ziegler, G., and Sloane, B.F. (1994). A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell Res. 214, 120-130.
36. Inoue, T, Ishida, T., Sugio, K., and Sugimachi, K. (1994). Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res. 54, 6133-6136.
37. Iwata, Y., Mort, J.S., Tateishi, H., and Lee, E.R. (1997). Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis. Arthritis Rheum. 40, 499-509.
38. Kalebic, T., Garbisa, S., Glaser, B., and Liotta, L.A. (1983). Basement membrane collagen: degradation by migrating endothelial cells. Science 221, 281-283.
39. Kasper, D., Dittmer, F., von Figura, K., and Pohlmann, R. (1996). Neither type of mannose 6-phosphate receptor is sufficient for targeting of lysosomal enzymes along intracellular routes. J. Cell Biol. 134, 615-623.
40. Keppler D., Sameni, M., Moin, K., Mikkelsen, T., Diglio, C.A., and Sloane, B.F. (1996). Tumor progression and angiogenesis: cathepsin B & Co. Biochem. Cell Biol. 74, 799-810.
41. Kerbel, R., Greig, R., and Frost, P. (1990): Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Cancer Metastasis Rev. 9, 171-282.
42. Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Gunzler, W.A., Janicke, F., Graeff, H. (1991). Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J. Biol. Chem. 266, 5147-5152.
43. Kos, J., Smid, A., Krasovec, M., Svetic, B., Lenarcic, B., Vrhovec, I., Skrk, J., and Turk, V. (1995). Lysosomal proteases cathepsins D, B, H, L, and there inhibitors stefins A and B in head and neck cancer. Biol. Chem. Hoppe-Seyler 376, 401-405.
44. Kos, J., Stabuc, B., Schweiger, A., Krasovec, M., Cimerman, N., Kopitar-Jerala, N., and Vrhovec, I. (1997). Cathepsin B,H, and L and there inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3, 1815-1822.
45. Kornfeld, S. (1990). Lysosomal enzyme targeting. Biochem. Soc. Trans. 18, 367-374.
46. Krepela, E., Kasafirek, E., Novak, K., and Viklicky, J. (1990). Increased cathepsin B activity in human lung tumors. Neoplasma 37, 61-70.
47. Krepela, E., Prochazka, J., Mynarikova, H., Karova, B., Polak, J., Cermak, J., and Roubkova, H. (1995). Multiple forms of cathepsin B in human lung cancer. Int. J. Cancer 61, 44-53.
48. Lah, T.T., Buck, M.R., Honn, K.V., Crissman, J.D., Rao, N.C., Liotta, L.A., and Sloane, B.F. (1989). Degradation of laminin by human tumor cathepsin B. Clin. Exp. Metastasis 7, 461-468.
49. Lah, T.T., Calaf, G., Kalman, E., Shinde, B.G., Russo, J., Jarosz, D., Zabrecky, J. Somers, R., and Daskal, I. (1995). Cathepsins D, B, and L in breast carcinoma and in transformed human breast epithelial cells (HBEC). Biol. Chem. Hoppe-Seyler 376, 357-363.
50. Lah, T.T., Kos, J., Blejec, A., Frkovic-Georgio, S., Golouh, R., Vrhovec, I., and Turk, V. (1997). The expression of lysosomal proteinases and there inhibitors in breast cancer: Possible relationship to prognosis of the disease. Pathol. Oncol. Res. 3, 89-99.
51. Laurie, G.W., and Leblond, C.P. (1983). What is known of the production of basement membrane components. J. Histochem. Cytochem. 31, (Suppl) 159-163.
52. Ledakis, P., Tester, W.T., Rosenberg, N., Romero-Fishmann, D., Daskal, I., and Lah, T.T. (1996). Cathepsins D, B, and L, in malignant human lung tissue. Clin. Cancer Res. 2, 561-568.
53. Lemaire, R., Huet, G., Zerimech, F., Grard, G., Fontaine, C., Duquesnoy, B., and Flipo, R-M. (1997). Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br. J. Rheumatol. 36, 735-743.
54. Leto, G., Tumminello, F.M., Resso, A., Pizzolanti, G., Bazen, V., and Gebbia, N. (1994). Cathepsin D activity levels in colorecta cancer: correlation with cathepsin B and Land other biological and clinical parameters. Int. J. Oncol. 5, 509-515.
55. Leto, G., Tumminello, F.M., Pizzolanti, G., Montalto, G., Soresi, M., and Gebbia, N. (1997a). Lysosomal cathepsins B and L and stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications. Oncol. 54, 79-83.
56. Leto, G., Tumminello, F.M., Pizzolanti, G., Montalto, G., Soresi, M., Carroccio, A., Ippolito, S., and Gebbia, N. (1997b). Lysosomal aspartic and cysteine proteinase serum levels in patients with pancreatic cancer or pancreatitis. Pancreas 14, 22-27.
57. Liotta, L. (1990). The role of cellular proteases and their inhibitors in invasion and metastasis. Introductory overview. Cancer Metastasis Rev. 9, 285-287.
58. Luthgens, K., Ebert, W., Trefz, G., Gabrijelcic, D., Turk, V., Lah, T. (1993). Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. Cancer Detect Prev. 17, 387-397.
59. MacDougall, J.R., and Matrisian, L.M. (1995). Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14, 351-362.
60. Mach, L., Stuwe, K., Hagen, A., Ballaun, C., and Glossl, J. (1992). Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme. Biochem. J. 282, 577-582.
61. Mackay, E.A., Ehrhard, A., Moniatte, M., Guenet, C., Tardif, C., Tarnus, C., Sorokine, O., Heintzelmann, B., Nay, C., Remy, J.M., Higaki, J., Van Dorsselaer, A., Wagner, J., Danzin, C., and Mamont, P. (1997). A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease. Eur. J. Biochem. 244, 414-425.
62. Mantle, D., Falkous, G., Ishiura, S., Perry, R.H., and Perry, E.K. (1995). Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's desease. J. Neurol. Sci. 131, 65-70.
63. Matrisian, L.M., and Bowden, G.T. (1990). Stromelysin/transin and tumor progression. Semin. Cancer Biol. 1, 107-115.
64. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P.(1997). Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16, 2319-2332.
65. McIntyre, G.F., and Erickson, A.H. (1993). The lysosomal proenzyme receptor that binds procathepsin L to microsomal membranes at pH 5 is a 43-kDa integral membrane protein. Proc. Natl. Acad. Sci. USA 90, 10588-10592.
66. Miqnatti, P., and Rifkin, D.B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 73, 161-195.
67. Mikkelsen, T., Yan, P-S., Ho, K.L., Sameni, M., Sloane, B.F., and Rosenblum, M.L. (1995). Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogene-progressive human proliferative breast disease. J. Nat. Cancer Inst. 85, 1725-1732.
68. Moin, K., Day, N.A., Sameni, M., Hasnain, S., Hirama, T., and Sloane, B.F. (1992). Human tumor cathepsin B. Comparison with normal liver cathepsin B. Biochem. J. 285, 427-434.
69. Murnane, M.J., Sheahan, K., Ozdemirli, M., and Shuja, S. (1991). Stage specific increase in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res. 51, 1137-1142.
70. Murphy, G., Ward, R., Gavrilovic, J., and Atkinson, S. (1992). Physiological mechanisms for metalloproteinase activation. Matrix. Suppl 1, 224-230.
71. Ochieng, J., Basolo, F., Albini, A., Melchiori, A., Watanabe, H., Elliott, J., Raz, A., Parodi, S., and Russo, J. (1991). Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. Invasion Metastasis 11, 38-47.
72. Ohsawa, T., Higashi, T., and Tsuji, T. (1989). The secretion of high molecular weight cathepsin B from cultured human liver cancers. Acta Med. Okayama 43, 9-15.
73. Oursler, M.J., Riggs, B.L., and Slpelsberg, T.C. (1993). Glucocorticoid-induced activation of latent transforming growth factor - by normal human osteoblast-like cells. Endocrinology 133, 2187-2196.
74. Ozeki, Y., Takishima, K., Takagi, K., Aida, S., Tamai, S., Mamiya, G., and Ogata, T. (1993). Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression. Jpn. J. Cancer Res. 84, 972-975.
75. Pagano, M., Dalet-Fumeron, V., and Engler, R. (1989). The glycosylation state of the precursors of the cathepsin B-like proteinase from human malignant ascitic fluid: possible implication in the secretory pathway of these proenzymes. Cancer Lett. 45, 13-19.
76. Page, A.E., Warburton, M.J., Pringle, J.A.S., and Hayman, A.R. (1992). Human osteoclastomas contain multiple forms of cathepsin B. Biochem. Biophys. Acta. 1116, 57-66.
77. Qian, F., Bajkowski, A.S., Steiner, D.F., Chan, S.J., and Frankfater, A. (1989). Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res. 49, 4870-4875.
78. Recklies, A.D., Tiltman, K.J., Stoker, T.A., and Poole, A.R. (1980). Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res. 40, 550-556.
79. Reddy, V.Y., Zhang, Q.Y., and Weiss, S.J. (1995). Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 92, 3849-3853.
80. Rempel, S.A., Rosenblum, M.L., Mikkelsen, T., Yan, P-S., Ellis, K.D., Golembieski, W.A., Sameni, M., Rozhin, J., Ziegler, G., and Sloane, B.F. (1994). Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54, 6027-6031.
81. Ren, W-P., and Sloane, B.F. (1996). Cathepsin B and D in breast cancer. In: Breast Cancer: Mammary Tumor Cell Cycle Differentiation and Metastasis. R.D. Dickson and M.E. Lippman, eds. (Boston: Kluwer), pp. 325-351.
82. Rifkin, B.R., Vernillo, A.T., Kleckner, A.P., Auszmann, J.M., Rosenberg, L.R., and Zimmerman, M. (1991). Cathepsin B and L activities in isolated osteoclasts. Biochem. Biophys. Res. Commun. 179, 63-69.
83. Rijnboutt, S., Aerts, H.M., Geuze, H.J., Tager, J.M., and Strous, G.J. (1991). Mannose 6-phosphate-independent membrane association of cathepsin D, glucocerebrosidase, and sphingo-lipid-activating protein in HepG2 cells. J. Biol. Chem. 266, 4862-4868.
84. Rodriguez, A., Webster, P., Ortego, J., and Andrews, N.W. (1997). Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J. Cell Biol. 137, 93-104.
85. Rozhin, J., Sameni, M., Ziegler, G., and Sloane, B.F. (1994). Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54, 6517-6525.
86. Sameni, M., Elliott, E., Ziegler, G., Fortgens, P.H., Dennison, C., and Sloane, B.F. (1995). Cathepsin B and cathepsin D are localized at the surface of human breast cancer cells. Pathol. Oncol. Res. 1, 43-53.
87. San Segundo, B., Chan, S.J., and Steiner, D.F. (1986). Difference in cathepsin B mRNA levels in normal human tissues suggested specialized functions. FEBS Lett. 201, 251-256.
88. Satoh, Y., Higashi, T., Nouso, K., Shiota, T., Kinugasa, N., Yoshida, K., Uematsu, S., Nakatsukasa, H., Nishimura, Y., and Tsuji, T. (1996). Cathepsin B in the growth of colorectal cancer: Increased activity of cathepsin B in human colorectal cancer. Acta Med. Okayama 50, 305-311.
89. Schmitt, M., Janicke, F., Moniwa, N., Chucholowski, N., Pache, L., and Graeff, H. (1992). Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol. Chem. Hoppe Seyler 373, 611-622.
90. Shintani, S., Alcalde, R.E., Matsumura, T., and Terakado, N. (1997). Extracellular matrices expression in invasion area of adenoid cystic carcinoma of salivary glands. Cancer Lett. 116, 9-14.
91. Shuja, S., and Murnane, M.J. (1996). Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease. Int. J. Cancer 66, 420-426.
92. Sinha, A.A., Gleason, D.F., Deleon, O.F., Wilson, M.J., and Sloane, B.F. (1993). Localization of biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat. Rec. 235, 233-240.
93. Sinha, A.A., Gleason, D.F., Staley, N.A., Wilson, M.J., Sameni, M., and Sloane, B.F. (1995). Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Anat. Rec. 241, 353-362.
94. Sivaparvathi, M., Sawaya, R., Wang, S.W., Rayford, A., Yamamoto, M., Liotta, L.A., Nicolson, G.L., and Rao, J.S. (1995). Overexpression and localization of cathepsin B during the progression of human gliomas. Clin. Exp. Metastasis 13, 49-56.
95. Sloane, B.F. (1996). Suicidal tumor proteases. Nature Biotechnology 14, 826-827.
96. Sloane, B.F., Rozhin, J., Hatfield, J.S., Crissman, J.D., and Honn, K.V. (1987). Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp. Cell Biol. 55, 209-224.
97. Sloane, B.F., Moin, K., Sameni, M., Tait, L.R., Rozhin, J., and Ziegler, G. (1994). Membrane-association of cathepsin B can be induced by transfection of human breast cells with c-Ha-ras oncogene. J. Cell Science 107, 373-384.
98. Strohmaier, A.R., Porwol, T., Acker, H., and Spiess, E. (1997). Tomography of cells by confocal laser scanning microscopy and computer-assisted three-dimensional image reconstruction: localization of cathepsin B in tumor cells penetrating collagen gels in vitro. J. Histochem. Cytochem. 45, 975-983.
99. Sukoh, N., Abe, S., Ogura, S., Isobe, H., Takekawa, H., Inoue, K., and Kawakami, Y. (1994). Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 74, 46-51.
100. Thomssen, C., Schmitt, M., Goretzki, L., Oppelt, P., Pache, L., Dettmar, P., Janicke, F., and Graeff, H. (1995). Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. Clin. Cancer Res. 1, 741-746.
101. Turk, B., Dolenc, I., Zerovnik, E., Turk, D., Gubensek, F., and Turk, V. (1994). Human cathepsin B is a metastable enzyme stabilized by specific ionic interactions associated with the active site. Biochemistry 33, 14800-14806.
102. Ulbricht, B., Hagmann, W., Ebert, W., and Spiess, E. (1996). Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxy-eicosatetraenoic acid. Exp. Cell Res. 226, 255-263.
103. Van der Stappen, J.W., Williams, A.C., Maciewicz, R.A., and Paraskeva, C. (1996). Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int. J. Cancer 67, 547-554.
104. Wang, X., Chan, S.J., Eddy, R.L., Byers, M.G., Fukushima, Y., Henry, L.L., Steiner, D.F., and Shows, T.B. (1988). Chromosome assignment of cathepsin B (CTSB) to 8p22 and cathepsin H (CTSH) to 15q24-q25. Cytogenet. Cell Genet. 46, 710-711.
105. Ward, C.J., Crocker, J., Chan, S.J., Stockley, R.A., and Burnett, D. (1990). Changes in expression of elastase and cathepsin B with differentiation of U937 promonocytes by GM-SCF. Biochem. Biophys. Res. Comm. 167, 659-664.
106. Weiss, R.E., Liu, B.C., Ahlering, T., Dubeau, L., and Droller, M.J. (1990). Mechanisms of human bladder tumor invasion: role of protease cathepsin B. J. Urol. 144, 798-804.
107. Werle, B., Ebert, W., Klein, W., and Spiess, E. (1994). Cathepsin B in tumors, normal tissue and isolated cells from the human lung. Anticancer Res. 14, 1169-1176.
108. Werle, B., Julke, B., Lah, T., Spiess, E., and Ebert, W. (1997). Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung. Br. J. Cancer 75, 1137-1143.
109. Yurchenco, P.D., and Schittny, J.C. (1990). Molecular architecture of basement membranes. FASEB J. 4, 1577-1590.